The cerebrospinal fluid (CSF) levels of Aβ, fragments, and p-Tau or total-Tau are extensively used biomarkers for AD [88,89], but their diagnostic accuracy varies between different centers [90]. This evidence concerns the gene MAPT and Alzheimer disease.